Tus Pharmaceutical Group Co Ltd Cash Flow-to-Debt Ratio
Tus Pharmaceutical Group Co Ltd cash flow-to-debt ratio. Tus Pharmaceutical Group Co Ltd (000590) has a Cash Flow-to-Debt Ratio of 0.01x as of September 2025, meaning its operating cash flow of CN¥2.24 Million could theoretically repay 0% of its total liabilities (CN¥359.74 Million) in one year. Check how aggressively does Tus Pharmaceutical Group Co Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Tus Pharmaceutical Group Co Ltd (1998–2025)
Cash flow-to-debt ratio of Tus Pharmaceutical Group Co Ltd from 1998 to 2025. Historical debt coverage capacity for Tus Pharmaceutical Group Co Ltd across 28 annual periods. Check earnings quality score of Tus Pharmaceutical Group Co Ltd to evaluate the quality of earnings relative to operating cash generation.
Tus Pharmaceutical Group Co Ltd Cash Flow-to-Debt Ratio by Year (1998–2025)
Tus Pharmaceutical Group Co Ltd cash flow-to-debt ratio by year from 1998 to 2025. Year-by-year debt coverage analysis for Tus Pharmaceutical Group Co Ltd. For the full cash flow conversion analysis, see 000590 cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.09x | CN¥28.96 Million | CN¥339.98 Million | ▲ +101.9% |
| 2024 | 0.04x | CN¥17.39 Million | CN¥412.18 Million | ▲ +162.8% |
| 2023 | -0.07x | CN¥-28.39 Million | CN¥422.92 Million | ▼ -157.2% |
| 2022 | 0.12x | CN¥54.47 Million | CN¥464.26 Million | ▲ +33.0% |
| 2021 | 0.09x | CN¥25.20 Million | CN¥285.50 Million | ▼ -57.6% |
| 2020 | 0.21x | CN¥51.48 Million | CN¥247.27 Million | ▲ +60.1% |
| 2019 | 0.13x | CN¥29.21 Million | CN¥224.58 Million | ▲ +4608.9% |
| 2018 | 0.00x | CN¥654.24K | CN¥236.88 Million | ▲ +100.9% |
| 2017 | -0.31x | CN¥-89.14 Million | CN¥290.40 Million | ▼ -246.2% |
| 2016 | -0.09x | CN¥-32.51 Million | CN¥366.72 Million | ▲ +44.1% |
| 2015 | -0.16x | CN¥-60.56 Million | CN¥381.64 Million | ▼ -25.5% |
| 2014 | -0.13x | CN¥-50.91 Million | CN¥402.71 Million | ▼ -968.0% |
| 2013 | 0.01x | CN¥4.12 Million | CN¥283.05 Million | ▼ -83.4% |
| 2012 | 0.09x | CN¥19.75 Million | CN¥225.44 Million | ▼ -28.6% |
| 2011 | 0.12x | CN¥30.87 Million | CN¥251.62 Million | ▼ -58.2% |
| 2010 | 0.29x | CN¥84.98 Million | CN¥289.85 Million | ▲ +144.8% |
| 2009 | 0.12x | CN¥34.14 Million | CN¥285.11 Million | ▼ -14.7% |
| 2008 | 0.14x | CN¥34.89 Million | CN¥248.53 Million | ▼ -50.2% |
| 2007 | 0.28x | CN¥68.04 Million | CN¥241.37 Million | ▲ +431.1% |
| 2006 | -0.09x | CN¥-23.33 Million | CN¥274.10 Million | ▼ -160.2% |
| 2005 | 0.14x | CN¥55.96 Million | CN¥396.04 Million | ▲ +19.3% |
| 2004 | 0.12x | CN¥48.46 Million | CN¥409.06 Million | ▲ +306.6% |
| 2003 | -0.06x | CN¥-24.43 Million | CN¥426.00 Million | ▼ -127.0% |
| 2002 | 0.21x | CN¥94.30 Million | CN¥443.96 Million | ▲ +273.4% |
| 2001 | -0.12x | CN¥-51.00 Million | CN¥416.40 Million | ▼ -481.2% |
| 2000 | 0.03x | CN¥8.23 Million | CN¥256.24 Million | ▲ +177.3% |
| 1999 | -0.04x | CN¥-10.35 Million | CN¥249.06 Million | ▼ -244.8% |
| 1998 | 0.03x | CN¥3.89 Million | CN¥135.56 Million | — |